Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

(2014) Shahrul Mt-Isa et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Modelling the risk-benefit impact of H1N1 influenza vaccines

(2013) L. D. Phillips et al.   EUROPEAN JOURNAL OF PUBLIC HEALTH

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

(2011) John W. Eikelboom et al.   CIRCULATION

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development of a Framework for Enhancing the Transparency, Reproducibility and Communication of the Benefit–Risk Balance of Medicines

(2010) P M Coplan et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: A single-center, retrospective, observational study

(2009) Laurie G. Jacobs et al.   American Journal Geriatric Pharmacotherapy

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE